Trial record 1 of 1 for:    royal marsden AND colorectal cancer AND methotrexate
Previous Study | Return to List | Next Study

Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency (MESH)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Royal Marsden NHS Foundation Trust.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Royal Marsden NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT00952016
First received: July 31, 2009
Last updated: December 3, 2013
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)